Meihua International Medical Technologies Co., Ltd. (MHUA) AI Stock Analysis

• Market Cap: $8.13M
• Dividend Yield: N/A
• Average Volume (3M): 84.65K
• Price to Earnings (P/E): 0.8
• Beta (1Y): 0.69
• Revenue Growth: -2.53%
• EPS Growth: 34.36%
• Country: US
• Employees: 617
• Sector: Healthcare
• Sector Strength: 76
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.38
• Shares Outstanding: 26,093,796
• 10 Day Avg. Volume: 62,570
• 30 Day Avg. Volume: 84,646
• PEG Ratio: 0.02
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.09
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Meihua International Medical Technologies has strong financial metrics and an undervalued stock price, but is challenged by technical indicators and cash flow issues. The lack of specific guidance from the earnings call leaves uncertainty about future performance, resulting in a moderate overall score.

Meihua International Medical Technologies Co., Ltd. Business Overview & Revenue Model

Company Description

Meihua International Medical Technologies Co., Ltd. (MHUA) is a company engaged in the manufacture and distribution of medical devices and healthcare products. The company operates within the medical technology sector and focuses on providing a range of essential healthcare products and solutions to meet the needs of medical professionals and patients.

How the Company Makes Money

Meihua International Medical Technologies Co., Ltd. generates revenue primarily through the sale of its medical devices and healthcare products. These products are distributed to hospitals, clinics, and other healthcare facilities, as well as directly to consumers. The company may also engage in partnerships with healthcare providers and distributors to expand its market reach and increase sales. Additionally, MHUA may invest in research and development to innovate and improve its product offerings, potentially leading to increased market share and revenue growth.

Meihua International Medical Technologies Co., Ltd. Financial Statement Overview

Summary

Meihua International Medical Technologies shows strong profitability with improving margins despite a revenue decline. The balance sheet is robust with low debt and high equity, indicating financial stability. However, cash flow issues persist, which need resolution for sustainable growth.

Income Statement

Meihua International Medical Technologies experienced a decline in total revenue from $103.35M in 2022 to $97.10M in 2023, indicating a negative revenue growth rate. However, the company maintained a strong gross profit margin of around 34.1% and improved its net profit margin from 6.04% in 2022 to 11.9% in 2023. Despite the revenue decline, increasing profitability margins suggest effective cost management.

Balance Sheet

The company's balance sheet shows a solid equity position with a high equity ratio of 85.2%. The debt-to-equity ratio remains low at 0.05, indicating low financial leverage and reduced risk of insolvency. Return on equity improved significantly from 4.5% in 2022 to 7.9% in 2023, demonstrating enhanced shareholder value creation.

Cash Flow

Cash flow analysis reveals a challenging scenario with negative free cash flow in both 2022 and 2023. However, operating cash flow improved from a negative $9.16M in 2022 to a positive $2.28M in 2023, indicating recovery in cash generation from operations. The free cash flow to net income ratio is negative, highlighting potential issues in cash conversion.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
94.25M	97.10M	103.35M	104.04M	89.06M	79.63M
	Gross Profit
31.11M	33.10M	38.10M	39.81M	37.16M	32.21M
	EBIT
11.47M	14.67M	15.57M	25.30M	23.47M	19.39M
	EBITDA
11.93M	15.77M	16.12M	26.88M	23.99M	19.90M
	Net Income Common Stockholders
9.28M	11.63M	6.24M	20.95M	19.05M	15.43M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
16.03M	16.93M	26.74M	8.15M	7.19M	16.03M
	Total Assets
73.20M	171.92M	163.58M	136.86M	106.05M	73.20M
	Total Debt
2.59M	7.33M	6.81M	5.18M	3.22M	2.59M
	Net Debt
-13.45M	-9.60M	-19.92M	-2.97M	-3.97M	-13.45M
	Total Liabilities
13.55M	25.08M	24.90M	30.05M	21.31M	13.55M
	Stockholders Equity
59.66M	146.33M	138.12M	106.81M	84.74M	59.66M
Cash Flow		Free Cash Flow
8.52M	-2.41M	-11.86M	-904.89K	-10.79M	356.12K
	Operating Cash Flow
8.72M	2.28M	-9.16M	-54.66K	5.33M	9.31M
	Investing Cash Flow
-14.02M	-12.46M	-8.62M	-833.82K	-16.09M	-8.90M
	Financing Cash Flow
6.12M	706.13K	37.25M	1.86M	1.71M	923.77K

Meihua International Medical Technologies Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.31
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MHUA, the sentiment is Negative. The current price of 0.31 is below the 20-day moving average (MA) of 0.33, below the 50-day MA of 0.33, and below the 200-day MA of 0.63, indicating a bearish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 48.33 is Neutral, neither overbought nor oversold. The STOCH value of 31.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MHUA.

Meihua International Medical Technologies Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TMDX	70 Outperform	$2.28B	66.99	19.39%	―	82.74%	―
ATRC	62 Neutral	$1.53B	―	-9.64%	―	16.55%	-44.89%
MHUA	57 Neutral	$8.13M	0.82	6.43%	―	-2.53%	34.36%
AXGN	54 Neutral	$719.26M	―	-9.99%	―	17.81%	54.69%
ICCC	52 Neutral	$48.15M	―	-8.21%	―	51.63%	62.32%
Sector *	48 Neutral	$6.36B	1.09	-49.92%	2.63%	17.17%	0.95%
NVCR	43 Neutral	$1.81B	―	-46.67%	―	18.82%	19.76%